SCHEMBL17470481

SCHEMBL17470481

c1ccc(-c2cccc(-c3nc4ccccc4[nH]3)c2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.76
RAB9A P51151 9/20 0.76
GAA P10253 2/20 0.76
SMN1; SMN2 Q16637 10/20 0.71
KDM4E B2RXH2 10/20 0.71
ALDH1A1 P00352 9/20 0.71
HPGD P15428 5/20 0.71
HSD17B10 Q99714 4/20 0.71
TP53 P04637 3/20 0.71
PKM P14618 3/20 0.62
ABCB11 O95342 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62
MAPT P10636 4/20 0.60
USP2 O75604 2/20 0.60
TDP1 Q9NUW8 1/20 0.60
PKN1 Q16512 1/20 0.59
PKN2 Q16513 1/20 0.59
PIM1 P11309 1/20 0.58
PIM3 Q86V86 1/20 0.58
AURKB Q96GD4 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3417301 0.94 NPC1 (0.78) NPC1RAB9AGAASMN1; SMN2KDM4E
SCHEMBL28027557 0.93 KDM4E (0.75) NPC1RAB9AGAASMN1; SMN2KDM4E
SCHEMBL12887920 0.91 NPC1 (0.63) NPC1RAB9AGAASMN1; SMN2KDM4E
SCHEMBL31592975 0.88 MMP2 (0.64) NPC1RAB9AGAASMN1; SMN2KDM4E
SCHEMBL2252555 0.87 NPC1 (0.92) NPC1RAB9AGAASMN1; SMN2KDM4E
Benzene SCHEMBL28005151 0.87 NPC1 (1.00) NPC1RAB9AGAASMN1; SMN2KDM4E
SCHEMBL105095 0.87 NPC1 (1.00) NPC1RAB9AGAASMN1; SMN2KDM4E
SCHEMBL12153689 0.87 NPC1 (0.77) NPC1RAB9AGAASMN1; SMN2KDM4E
SCHEMBL23132010 0.85 SMN1; SMN2 (0.61) NPC1RAB9AGAASMN1; SMN2KDM4E
Potassium SCHEMBL4891434 0.85 NPC1 (0.96) NPC1RAB9AGAASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022117473-A1 HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-06-09 WO disclosed
EP-3172775-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2022-04-20 EP disclosed
US-20170222157-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-08-03 US disclosed
US-20170222157-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-08-03 US disclosed
WO-2016012075-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2016-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170222157-A1 MATERIALS FOR ELECTRONIC DEVICES EYA3, EYA2, MITF NPC1 2290/4885RAB9A 1446/4885GAA 3195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.